Clinical trials
Terminated Endocrine System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Pfizer | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bracane Company | 1 |
| CRISPR Therapeutics AG | 1 |
| CeQur Corporation | 1 |
| Clear Passage Therapies, Inc | 1 |
| Denver Health and Hospital Authority | 1 |
| Goldfinch Bio, Inc. | 1 |
| Lakewood-Amedex Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 20 |
| Diabetes Mellitus | 9 |
| Glucose Metabolism Disorders | 7 |
| Metabolic Diseases | 6 |
| Cardiovascular Diseases | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Chronic Disease | 2 |
| Diabetes Complications | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Digestive System Diseases | 2 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.